126 related articles for article (PubMed ID: 30958629)
21. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.
Clark PJ; Stuart KA; Leggett BA; Crawford DH; Boyd P; Fawcett J; Whiteman DC; Baade PD
Liver Int; 2015 Dec; 35(12):2584-94. PubMed ID: 25900432
[TBL] [Abstract][Full Text] [Related]
22. Trends in cancer incidence in Maputo, Mozambique, 1991-2008.
Lorenzoni C; Vilajeliu A; Carrilho C; Ismail MR; Castillo P; Augusto O; García-Basteiro AL; Sidat M; de Sanjosé S; Menéndez C; Ordi J
PLoS One; 2015; 10(6):e0130469. PubMed ID: 26110774
[TBL] [Abstract][Full Text] [Related]
23. Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method.
Yeesoonsang S; Bilheem S; McNeil E; Iamsirithaworn S; Jiraphongsa C; Sriplung H
Cancer Res Treat; 2017 Jan; 49(1):54-60. PubMed ID: 27188200
[TBL] [Abstract][Full Text] [Related]
24. Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies.
Turcanu A; Pitel E; Dumbrava VT; Tcaciuc E; Donscaia A; Peltec A; Pineau P
Rom J Intern Med; 2019 Mar; 57(1):37-46. PubMed ID: 30375353
[TBL] [Abstract][Full Text] [Related]
25. [Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000-2014].
Zhang SW; Zheng RS; Yang ZX; Zeng HM; Sun KX; Gu XY; Li H; Chen WQ; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jun; 52(6):579-585. PubMed ID: 29886678
[No Abstract] [Full Text] [Related]
26. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
[TBL] [Abstract][Full Text] [Related]
27. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
[TBL] [Abstract][Full Text] [Related]
28. Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007.
Sitas F; Gibberd A; Kahn C; Weber MF; Chiew M; Supramaniam R; Velentzis L; Nickson C; Smith DP; O'Connell D; Smith MA; Armstrong K; Yu XQ; Canfell K; Robotin M; Feletto E; Penman A
Cancer Epidemiol; 2013 Dec; 37(6):780-7. PubMed ID: 24183782
[TBL] [Abstract][Full Text] [Related]
29. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.
Bach AC; Lo KS; Pathirana T; Glasziou PP; Barratt AL; Jones MA; Bell KJ
Med J Aust; 2020 Jan; 212(1):17-22. PubMed ID: 31691294
[TBL] [Abstract][Full Text] [Related]
30. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
Chang MH; Chen CJ; Lai MS; Hsu HM; Wu TC; Kong MS; Liang DC; Shau WY; Chen DS
N Engl J Med; 1997 Jun; 336(26):1855-9. PubMed ID: 9197213
[TBL] [Abstract][Full Text] [Related]
31. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017.
Liu Z; Suo C; Mao X; Jiang Y; Jin L; Zhang T; Chen X
Cancer; 2020 May; 126(10):2267-2278. PubMed ID: 32201944
[TBL] [Abstract][Full Text] [Related]
32. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation.
Burton A; Tataru D; Driver RJ; Bird TG; Huws D; Wallace D; Cross TJS; Rowe IA; Alexander G; Marshall A;
JHEP Rep; 2021 Apr; 3(2):100232. PubMed ID: 33748727
[TBL] [Abstract][Full Text] [Related]
33. 20-years of population-based cancer registration in hepatitis B and liver cancer prevention in the Gambia, West Africa.
Bah E; Carrieri MP; Hainaut P; Bah Y; Nyan O; Taal M
PLoS One; 2013; 8(9):e75775. PubMed ID: 24098724
[TBL] [Abstract][Full Text] [Related]
34. Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
Rutherford MJ; Arnold M; Bardot A; Ferlay J; De P; Tervonen H; Little A; Bucher O; St Jacques N; Gavin A; Engholm G; Møller B; O'Connell DL; Merrett N; Parkin DM; Bray F; Soerjomataram I
Int J Cancer; 2021 Dec; 149(12):2020-2031. PubMed ID: 34460109
[TBL] [Abstract][Full Text] [Related]
35. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
[TBL] [Abstract][Full Text] [Related]
36. Cancer in the Gambia: 1988-97.
Bah E; Parkin DM; Hall AJ; Jack AD; Whittle H
Br J Cancer; 2001 May; 84(9):1207-14. PubMed ID: 11336472
[TBL] [Abstract][Full Text] [Related]
37. Rising incidence of primary liver cancer in Brunei Darussalam.
Chong RJ; Abdullah MS; Hossain MM; Telisinghe PU; Chong VH
Asian Pac J Cancer Prev; 2013; 14(6):3473-7. PubMed ID: 23886131
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
[TBL] [Abstract][Full Text] [Related]
39. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma over three decades in Victoria, Australia: epidemiology, diagnosis and trends, 1984-2013.
Carville KS; MacLachlan JH; Thursfield V; Cowie BC
Intern Med J; 2018 Jul; 48(7):835-844. PubMed ID: 29604152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
